Consider this: British Columbia Investment Management Corporation manages approximately $250-billion in assets. A reallocation of just two percentage points toward domestic private equity would represent $5-billion in incremental capital targeting Canadian deals. For founders, this is a market-moving shift.

Institutional reallocations are rarely announced with fanfare. However, signals are accumulating in quarterly reports, mandate disclosures, and deal flow data. Both BCI and OMERS have moved to increase exposure to domestic private equity after a long period where offshore assets—including US buyouts, European infrastructure, and Asian growth equity—dominated their alternative allocations.

For BC founders seeking $10–50M in growth capital, the landscape has changed over the past 18 months. Local institutional capital is re-entering the mid-market just as valuations have compressed from 2021 peaks and deal flow remains steady. This convergence of more capital, lower entry prices, and motivated sellers is a rare opportunity.

Macro forces converge

Two structural forces are making domestic deployment increasingly attractive.

First, interest rate normalization. The Bank of Canada’s rate cycle has shifted the relative appeal of asset classes, favouring private equity over fixed income. When the overnight rate hovered near zero, institutions pursued offshore alternatives to meet return targets. As rates have normalized, domestic private equity deals—particularly in the $10–50M range—can now meet hurdle rates without the geopolitical and currency risks inherent in offshore exposure.

Second, the Canadian dollar. A softer loonie makes domestic assets more affordable for institutions that mark to Canadian dollars and enhances the competitiveness of Canadian exporters. The CAD/USD rate has provided a meaningful tailwind for domestic deal economics over the past 18 months, a trend BCI’s investment teams are monitoring closely.

What the data shows

CVCA data for the first half of 2026 shows strengthening Canadian private equity activity, with mid-market transactions—typically between $25M and $500M in enterprise value—accounting for a larger share of volume. More significantly, EV/EBITDA multiples for Canadian mid-market buyouts have compressed from the 2021 peaks, when cheap debt and optimistic growth projections inflated entry multiples.

While compressed multiples mean lower valuations for sellers, they offer an advantage for founders raising growth equity. By selling a minority stake to fund expansion, these founders give up less of their company per dollar raised.

BCI’s domestic mandate

BCI has articulated a preference for Canadian private equity exposure in its investment strategy, framing domestic deployment as both a return opportunity and a mandate aligned with the public sector workers whose pensions it manages. The firm is active in Canadian mid-market buyouts and growth equity, often participating as a limited partner in funds managed by Canadian GPs, while simultaneously expanding its direct investment capabilities.

OMERS maintains a distinct approach, with its BC presence largely driven by OMERS Ventures, which remains an active backer of Canadian technology companies.

Strategic implications for founders

Understanding institutional mandates provides a significant negotiating advantage. A founder who knows that a growth equity firm’s LP base includes BCI—and that BCI is under pressure to deploy domestically—approaches the negotiation with a clearer view of the room.

For founders in the $10–50M raise range, consider these factors:

  • Intermediaries matter: Mid-market M&A advisers and placement agents in Vancouver hold real-time intelligence on active mandates. A process managed by an adviser with institutional relationships often surfaces capital that direct outreach cannot.
  • The window is finite: Institutional allocation cycles are long but not permanent. If the Bank of Canada resumes aggressive easing or offshore markets offer superior risk-adjusted returns, the domestic thesis may weaken. Founders who move within the next 12–18 months may face a more favourable environment than those who wait until 2028.
  • Institutional standards: BCI and its partners require rigorous diligence. ESG documentation, audited financials, and robust governance are table stakes. Founders should prepare for institutional-grade scrutiny rather than venture-style expectations.

What to watch:

  • BCI’s next quarterly report for updates on domestic private equity targets.
  • CVCA’s Q3 2026 data to track the momentum of Canadian mid-market deals.
  • Bank of Canada rate decisions: Any shift toward aggressive easing will alter the return calculus for institutional allocators.
  • CAD/USD movements: Sustained strength in the loonie above 0.76 would reduce the currency tailwind currently favouring domestic deals.